Shanghai Pharmaceuticals Holding Co Ltd (601607) — Cash Flow Reinvestment Rate
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow Reinvestment Rate of 0.31x as of September 2025, reinvesting CN¥487.63 Million (capex CN¥487.63 Million ) from operating cash flow of CN¥1.56 Billion. Check cash flow quality index of Shanghai Pharmaceuticals Holding Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Shanghai Pharmaceuticals Holding Co Ltd across 27 annual periods. Explore 601607 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shanghai Pharmaceuticals Holding Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Shanghai Pharmaceuticals Holding Co Ltd. For live market cap and broader valuation context, see Shanghai Pharmaceuticals Holding Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | CN¥3.72 Billion | CN¥6.15 Billion | CN¥2.33 Billion | ▼ -37.4% |
| 2024 | 0.97x | CN¥5.62 Billion | CN¥5.83 Billion | CN¥2.40 Billion | ▼ -7.6% |
| 2023 | 1.04x | CN¥5.46 Billion | CN¥5.23 Billion | CN¥2.97 Billion | ▼ -67.3% |
| 2022 | 3.20x | CN¥15.16 Billion | CN¥4.74 Billion | CN¥2.68 Billion | ▲ +284.6% |
| 2021 | 0.83x | CN¥4.21 Billion | CN¥5.06 Billion | CN¥4.12 Billion | ▲ +49.0% |
| 2020 | 0.56x | CN¥3.82 Billion | CN¥6.84 Billion | CN¥3.01 Billion | ▼ -36.3% |
| 2019 | 0.88x | CN¥5.28 Billion | CN¥6.02 Billion | CN¥2.75 Billion | ▲ +6.1% |
| 2018 | 0.83x | CN¥2.59 Billion | CN¥3.14 Billion | CN¥1.94 Billion | ▼ -2.0% |
| 2017 | 0.84x | CN¥2.23 Billion | CN¥2.65 Billion | CN¥2.01 Billion | ▼ -67.3% |
| 2016 | 2.57x | CN¥5.01 Billion | CN¥1.95 Billion | CN¥2.12 Billion | ▲ +78.6% |
| 2015 | 1.44x | CN¥1.94 Billion | CN¥1.35 Billion | CN¥1.72 Billion | ▲ +49.0% |
| 2014 | 0.97x | CN¥1.29 Billion | CN¥1.34 Billion | CN¥1.29 Billion | ▲ +4.0% |
| 2013 | 0.93x | CN¥905.06 Million | CN¥973.45 Million | CN¥905.06 Million | ▲ +50.9% |
| 2012 | 0.62x | CN¥708.91 Million | CN¥1.15 Billion | CN¥708.91 Million | ▲ +164.0% |
| 2011 | 0.23x | CN¥413.54 Million | CN¥1.77 Billion | CN¥413.54 Million | ▼ -28.5% |
| 2010 | 0.33x | CN¥550.30 Million | CN¥1.69 Billion | CN¥550.30 Million | ▲ +171.1% |
| 2009 | 0.12x | CN¥79.97 Million | CN¥664.13 Million | CN¥79.97 Million | ▼ -62.0% |
| 2008 | 0.32x | CN¥90.50 Million | CN¥285.68 Million | CN¥90.50 Million | ▼ -19.4% |
| 2007 | 0.39x | CN¥192.29 Million | CN¥488.94 Million | CN¥192.29 Million | ▲ +51.3% |
| 2006 | 0.26x | CN¥151.60 Million | CN¥583.11 Million | CN¥151.60 Million | ▼ -90.4% |
| 2005 | 2.71x | CN¥198.09 Million | CN¥73.00 Million | CN¥198.09 Million | ▼ -34.2% |
| 2004 | 4.13x | CN¥254.38 Million | CN¥61.66 Million | CN¥254.38 Million | ▼ -98.8% |
| 2003 | 350.18x | CN¥169.58 Million | CN¥484.27K | CN¥169.58 Million | ▲ +12537.3% |
| 2002 | 2.77x | CN¥279.44 Million | CN¥100.84 Million | CN¥279.44 Million | ▲ +25.9% |
| 2001 | 2.20x | CN¥144.71 Million | CN¥65.73 Million | CN¥144.71 Million | ▲ +128.2% |
| 2000 | 0.96x | CN¥141.09 Million | CN¥146.22 Million | CN¥141.09 Million | ▲ +202.8% |
| 1999 | 0.32x | CN¥52.48 Million | CN¥164.67 Million | CN¥52.48 Million | — |